CNS Digital Therapeutics Market by Disease Indication (Alzheimers disease, Parkinsons disease and Epilepsy), End Users (Providers, Payers, Patients and Pharmaceutical Companies) – Analysis & Forecast 2019-2030

Report ID : 105  |  Published Date : May 2020  |  Pages : 210  |  Region : Global  |  Report Code : HIT-7




Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Ecosystem
      1.  Market Classification
      2.  Geographic Scope
      3.  Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
    3. Currency Used
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1.  Secondary Sources
      2.  Primary Sources
    4. Market Estimation Methodology
      1.  Bottoms Up Approach
      2.  Top Down Approach
    5. Data Validation and Triangulation
      1. Limitations/Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Product Portfolio Assessment
    2. Winning Imperative: Seeking Investments for Achieving Sustainable Development Goals
  6. GLOBAL CNS DIGITAL THERAPEUTICS MARKET- ANALYSIS & FORECAST, BY DISEASE INDICATION
    1.  Alzheimer's Disease
    2.  Parkinson's Disease
    3.  Epilepsy
    4.  Other Disease Indications
  7. GLOBAL CNS DIGITAL THERAPEUTICS MARKET- ANALYSIS & FORECAST, BY END USERS   
    1. Providers
    2. Payers
    3. Patients
    4. Pharmaceutical Companies
  8. GLOBAL CNS DIGITAL THERAPEUTICS MARKET- ANALYSIS & FORECAST, BY REGION
    1.   North America CNS Digital Therapeutics Drugs Market
      1.  North America CNS Digital Therapeutics Market, By Country
        1. US
        2. Canada
      2. North America CNS Digital Therapeutics Market Analysis & Forecast, By Disease Indication
      3. North America CNS Digital Therapeutics Market Analysis & Forecast, By  End User
    2. Europe CNS Digital Therapeutics Market
      1. Europe CNS Digital Therapeutics Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe CNS Digital Therapeutics Market Analysis & Forecast, By Disease   Indication
      3. Europe CNS Digital Therapeutics Market Analysis & Forecast, By End User
    3. Asia Pacific CNS Digital Therapeutics Market
      1. Asia Pacific CNS Digital Therapeutics Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific CNS Digital Therapeutics Market Analysis & Forecast, By Disease Indication
      3. Asia Pacific CNS Digital Therapeutics Market Analysis & Forecast, By End User
    4.   Rest of the World (ROW) CNS Digital Therapeutics Market
      1. Rest of the World CNS Digital Therapeutics Market , By Country/ Region
      2. Rest of the World CNS Digital Therapeutics Market Analysis & Forecast, By Disease Indication
      3. Rest of the World CNS Digital Therapeutics Market Analysis & Forecast, By End User
  9. COMPETETIVE LANDSCAPE
    1. Key Players & Their Competitive Positioning (2018)
    2. Key Strategies Assessment
      1. Investments
      2. Product Launch/Patent/Release/Approval/License
      3. Agreement/Collaboration/Partnership
  10. COMPANY PROFILES (Business Overview, Product Offered, Financial Performance*, Recent Developments)*
    1.   Pear Therapeutics, Inc.
    2.   Dthera Sciences
    3.   Akili Interactive Labs, Inc.
    4.   Epicadence
    5.   CLICK THERAPEUTICS, INC.
    6.   Cognoa
    7.   GAIA AG
    8.   MindSciences
    9.   Brainmarc
    10. MedRhythms

*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain